Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  MedicationBG ControlType 1 DiabetesMedical DevicesInsulinGlucose MonitoringIssue 731

AACE: New Guidance on Insulin Pumps

In order for a patient to obtain maximum benefit from an insulin pump, uniform training programs must be developed.... 

Advertisement

George Grunberger, MD, president of AACE stated in an updated consensus statement that, "The organization acknowledges that pumps have become more sophisticated, and in order to obtain maximum benefit, training programs should be developed." According to that statement, which was published in Endocrine Practice, an update to earlier guidance from 2010 offered recommendations for patients who are on pump therapy with both type 1 and type 2 diabetes. It addresses the benefits of pump therapy, which include: pump therapy has benefits over multiple daily injections, better outcomes in regards to glycemic control, quality of life improvements, and severe hypoglycemia reductions.

The guidance provides an update on the state of technology and improvements to functional features of the pump. These improvements can be maximized if providers offer comprehensive training programs to patients.

Dr. Grunberger made several recommendations for creating a uniform training program including that the right people should be on the pumps and the people on pump therapy should be trained well. Some of the challenges in using pump therapy were also outlined including one of the biggest, that Medicare no longer covers CGM for pump therapy in patients over 65.

Practice Pearls:
  • Pump therapy has benefits over multiple daily injections, better outcomes in regards to glycemic control, quality of life improvements, and severe hypoglycemia reductions.
  • The guidance provides an update on the state of technology and improvements to functional features of the pump.
  • Medicare no longer covers CGM for pump therapy in patients over 65

Grunberger G, et al "Consensus statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force" Presented at the 2014 AACE meeting. 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 29 May, 2014 and appeared in  MedicationBG ControlType 1 DiabetesMedical DevicesInsulinGlucose MonitoringIssue 731

Past five issues: Diabetes Clinical Mastery Series Issue 252 | SGLT-2 Inhibitors Special Edition July 2015 | Issue 792 | Diabetes Clinical Mastery Series Issue 251 | Issue 791 |

2015 Most Popular Articles:

Self-Monitoring of Blood Glucose: The Patient's Perspective
Posted July 10, 2015
The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Weight Reduction
Posted July 10, 2015
Vitamin D3 Supplementation and Weight Loss Prevent Cancer in Older Women
Posted July 10, 2015
GLP-1 Receptor Agonists Reduce Bone Loss During Weight Loss
Posted July 17, 2015
Diet That Mimics Fasting Appears to Slow Aging
Posted July 03, 2015
Metformin May Increase Mortality in Advanced CKD among Type 2 Patients
Posted July 10, 2015
Evaluation of Cellphone Application that Records Readings from Glucometer
Posted July 10, 2015
Impact of Exercise in Type 2 Diabetes Patients
Posted July 23, 2015
Ancestral Diets Can Determine Vulnerability to Type 2 Diabetes
Posted July 17, 2015
Two Gene Mutations Identified in Increased Risk of Obesity and Diabetes
Posted July 23, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
Do you have any patients on a dual therapy of a DPP-4 and a SGLT-2 who have reached their goal A1c?

CME/CE of the Week
Vickie Driver, DPM, MS, FACFAS

Category: Wound Care
Credits: 1.0